In vivo anti viral activity of a pyrazole compound win 41258 3 against herpes simplex virus type 2 in a mouse genital infection
Pancic, F.; Steinberg, B.; Diana, G.; Came, P.
Abstracts of the Annual Meeting of the American Society for Microbiology 78: 262
1978
ISSN/ISBN: 0094-8519
Accession: 026780042
PDF emailed within 1 workday: $29.90
Related References
Pancic, F.; Steinberg, B.A.; Diana, G.D.; Carabateas, P.M.; Gorman, W.G.; Came, P.E. 1981: Antiviral activity of Win 41258-3, a pyrazole compound, against herpes simplex virus in mouse genital infection and in guinea pig skin infection Antimicrobial Agents and ChemoTherapy 19(3): 470-476Lin, T.-L.; Cheng, C.; Zeng, W.-T.; Duan, F.; Pei, Y.-H.; Liu, X.-P.; Shang, F.; Wu, K.-L. 2021: Anti-viral activity of Staphylococcus aureus lysates against herpes simplex virus type-i infection: an in vitro and in vivo study International Journal of Ophthalmology 14(10): 1463-1472
Schabel, F.M.Jr 1968: The anti viral activity of 9 beta d arabinofuranosyl adenine anti viral mouse rabbit hamster herpes keratitis virus herpes simplex virus vaccinia virus Chemotherapy 13(6): 321-338
Nazli, A.; Yao, X.-D.; Smieja, M.; Rosenthal, K.L.; Ashkar, A.A.; Kaushic, C. 2009: Differential induction of innate anti-viral responses by TLR ligands against Herpes simplex virus, type 2, infection in primary genital epithelium of women Antiviral Research 81(2): 103-112
Peterson, E.; Schmidt, O.W.; Goldstein, L.C.; Nowinski, R.C.; Corey, L. 1983: Typing of clinical herpes simplex virus isolates with mouse monoclonal antibodies to herpes simplex virus types 1 and 2: comparison with type-specific rabbit antisera and restriction endonuclease analysis of viral DNA Journal of Clinical Microbiology 17(1): 92-96
Milligan, G.N.; Bernstein, D.I. 1995: Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2 Virology 212(2): 481-489
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Pei, Y.; Chen, Z.-P.; Ju, H.-Q.; Komatsu, M.; Ji, Y.-h.; Liu, G.; Guo, C.-w.; Zhang, Y.-J.; Yang, C.-R.; Wang, Y.-F.; Kitazato, K. 2011: Autophagy is involved in anti-viral activity of pentagalloylglucose (PGG) against Herpes simplex virus type 1 infection in vitro Biochemical and Biophysical Research Communications 405(2): 186-191
Stanberry, L.R.; Kit, S. 1984: Re infection with wild type herpes simplex virus type 2 after primary genital infection with a thymidine kinase deficient herpes simplex virus type 2 mutant Journal of Cellular Biochemistry Suppl (8 Part B): 208
Lafferty, W.E.; Coombs, R.W.; Benedetti, J.; Critchlow, C.; Corey, L. 1987: Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type New England Journal of Medicine 316(23): 1444-1449
Lafferty, W.E.; Coombs, R.W.; Benedetti, J.; Critchlow, C.; Corey, L. 1987: Recurrence after oral and genital herpes simplex virus infection. Influence of site of infection and viral type The new England Journal of Medicine 316(23): 1444-1449
Sturn, B.; Schneweis, K.E. 1978: Protective effect of an oral infection with herpes simplex virus type 1 against subsequent genital infection with herpes simplex virus type 2 Medical Microbiology and Immunology 165(2): 119-127
Quispe Calla, N.E.; Vicetti Miguel, R.D.; Torres, A.R.; Trout, W.; Gabriel, J.M.; Hatfield, A.M.; Aceves, K.M.; Kwiek, J.J.; Kaur, B.; Cherpes, T.L. 2020: Norethisterone Enanthate Increases Mouse Susceptibility to Genital Infection with Herpes Simplex Virus Type 2 and HIV Type 1 Immunohorizons 4(2): 72-81
Guglielmino, S.; Corbino, N.; Nuciforo, G.; Petrina, M.; Tempera, G.; Garozzo, A.; Castro, A.; Cianci, S. 1985: Levels of anti herpes simplex virus viral capsid antigen circulating antibodies in women with papovavirus genital infection Archives of Gynecology 237(Suppl): 84
Valencia, F.; Bubar, M.J.; Milligan, G.; Cunningham, K.A.; Bourne, N. 2012: Influence of methamphetamine on genital herpes simplex virus type 2 infection in a mouse model Sexually Transmitted Diseases 39(9): 720-725